ALDOSTERONE SYNTHASE INHIBITION WITH OR WITHOUT BACKGROUND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITION IN CKD: A PHASE II CLINICAL TRIAL

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/c5ee389920d675b1fcf1403a005bdac3.pdf

Abstract Title

First Name *

Katherine

Last Name *

Tuttle

Co-author 1

Sibylle Hauske sibylle.hauske@boehringer-ingelheim.com Boehringer Ingelheim International GmbH CMR Medicine Ingelheim am Rhein Vth Department of Medicine, University Medical Center Mannheim, Heidelberg University

Co-author 2

Shimoli V Shah shimoli.shah@boehringer-ingelheim.com Boehringer Ingelheim Pharmaceuticals Inc. Global Patient Safety & Pharmacovigilance Ridgefield

Co-author 3

Lisa Cronin lisa.cronin@boehringer-ingelheim.com Boehringer Ingelheim Pharmaceuticals Inc. CardioMetabolism & Respiratory Medicine Ridgefield

Co-author 4

Zhichao Sun zhichao.sun@boehringer-ingelheim.com Boehringer Ingelheim Pharmaceuticals Inc. Global Biostatistics & Data Sciences Ridgefield

Co-author 5

Dick de Zeeuw ZeeuwDrugAdvice@outlook.com University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology Groningen

Co-author 6

Hiddo J L Heerspink h.j.lambers.heerspink@umcg.nl University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology Groningen

Co-author 7

Peter Rossing peter.rossing@regionh.dk Steno Diabetes Center Copenhagen Complications Research Copenhagen

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15